drugset
drugset / Trial / NCT03557112

By Comparing TPF Induction Chemotherapy Combined With Nimotuzumab Concurrent Radiotherapy and Cisplatin Concurrent Radio-chemotherapy for Locally Advanced NPC

NCT03557112 ↗

Phase 2 Unknown 180 enrolled Guiyang Medical University
Non-randomizedParallel-groupDouble-blindTreatment

Summary

This study is aimed to investigate the short-term efficacy and toxicities of local advanced nasopharyngeal carcinoma (NPC) treated with TPF regimen induction chemotherapy combined with nimotuzumab concurrent radiotherapy and cisplatin concurrent chemoradiotherapy.

Timeline

Start
2018-06-01
Primary completion
2021-06-01
Completion
2021-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cisplatin Other / unclassified — —
Subject Nimotuzumab Monoclonal antibody — —

Indications

nasopharyngeal carcinoma